Matches in SemOpenAlex for { <https://semopenalex.org/work/W1837421878> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W1837421878 endingPage "1100" @default.
- W1837421878 startingPage "1091" @default.
- W1837421878 abstract "The safety and efficacy of captopril therapy in children with severe and refractory hypertension has been evaluated in a collaborative international study which enrolled a group of 73 patients, 15 years of age or younger. Most patients had hypertension associated with renal disease or vascular abnormalities. Captopril was administered for periods of less than 3 months to more than 1 year. A significant decrease in both systolic and diastolic blood pressures was produced by the administration of captopril, usually in conjunction with other antihypertensive agents (most commonly diuretics and/ or β-blockers). Systolic blood pressures were normalized in 62% and 53% and diastolic blood pressures in 56% and 45% of reported patients after the second and sixth months of captopril therapy, respectively. The response to captopril was sustained over a 12-month period. Adverse reactions were reported in 49% of the 73 patients; 48% of patients had experienced adverse reactions to other antihypertensive agents prior to entering the study. The reactions most frequently observed during captopril therapy were hypotension, vomiting, postural symptoms, anemia, rash, and anorexia. Leukopenia was reported in six patients, all of whom had renal impairment. Two of these patients had received concomitant therapy with immunosuppressants, and one had systemic lupus erythematosus. Captopril was discontinued in two of these six children. Statistically significant increases in mean serum urea nitrogen and potassium concentrations and decreases in mean serum CO2 levels were observed during the course of therapy. These effects could not be exclusively attributed to captopril administration as the study population received multidrug therapy and had significant intrinsic disease. Captopril was demonstrated to be an effective and safe drug for the treatment of children with severe hypertension." @default.
- W1837421878 created "2016-06-24" @default.
- W1837421878 creator A5019273826 @default.
- W1837421878 creator A5061744858 @default.
- W1837421878 date "1985-06-01" @default.
- W1837421878 modified "2023-10-05" @default.
- W1837421878 title "Efficacy and Safety of Captopril in the Treatment of Severe Childhood Hypertension: Report of the International Collaborative Study Group" @default.
- W1837421878 doi "https://doi.org/10.1542/peds.75.6.1091" @default.
- W1837421878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3889818" @default.
- W1837421878 hasPublicationYear "1985" @default.
- W1837421878 type Work @default.
- W1837421878 sameAs 1837421878 @default.
- W1837421878 citedByCount "51" @default.
- W1837421878 countsByYear W18374218782013 @default.
- W1837421878 countsByYear W18374218782014 @default.
- W1837421878 countsByYear W18374218782016 @default.
- W1837421878 countsByYear W18374218782017 @default.
- W1837421878 countsByYear W18374218782018 @default.
- W1837421878 countsByYear W18374218782019 @default.
- W1837421878 countsByYear W18374218782020 @default.
- W1837421878 countsByYear W18374218782022 @default.
- W1837421878 countsByYear W18374218782023 @default.
- W1837421878 crossrefType "journal-article" @default.
- W1837421878 hasAuthorship W1837421878A5019273826 @default.
- W1837421878 hasAuthorship W1837421878A5061744858 @default.
- W1837421878 hasConcept C126322002 @default.
- W1837421878 hasConcept C197934379 @default.
- W1837421878 hasConcept C2776694085 @default.
- W1837421878 hasConcept C2778176769 @default.
- W1837421878 hasConcept C2778570526 @default.
- W1837421878 hasConcept C2779479957 @default.
- W1837421878 hasConcept C2780306776 @default.
- W1837421878 hasConcept C2780873365 @default.
- W1837421878 hasConcept C71924100 @default.
- W1837421878 hasConcept C84393581 @default.
- W1837421878 hasConceptScore W1837421878C126322002 @default.
- W1837421878 hasConceptScore W1837421878C197934379 @default.
- W1837421878 hasConceptScore W1837421878C2776694085 @default.
- W1837421878 hasConceptScore W1837421878C2778176769 @default.
- W1837421878 hasConceptScore W1837421878C2778570526 @default.
- W1837421878 hasConceptScore W1837421878C2779479957 @default.
- W1837421878 hasConceptScore W1837421878C2780306776 @default.
- W1837421878 hasConceptScore W1837421878C2780873365 @default.
- W1837421878 hasConceptScore W1837421878C71924100 @default.
- W1837421878 hasConceptScore W1837421878C84393581 @default.
- W1837421878 hasIssue "6" @default.
- W1837421878 hasLocation W18374218781 @default.
- W1837421878 hasLocation W18374218782 @default.
- W1837421878 hasOpenAccess W1837421878 @default.
- W1837421878 hasPrimaryLocation W18374218781 @default.
- W1837421878 hasRelatedWork W1837421878 @default.
- W1837421878 hasRelatedWork W1984827835 @default.
- W1837421878 hasRelatedWork W2123976575 @default.
- W1837421878 hasRelatedWork W2406657335 @default.
- W1837421878 hasRelatedWork W2408378336 @default.
- W1837421878 hasRelatedWork W2409947088 @default.
- W1837421878 hasRelatedWork W2802498238 @default.
- W1837421878 hasRelatedWork W4253465300 @default.
- W1837421878 hasRelatedWork W55572913 @default.
- W1837421878 hasRelatedWork W70720832 @default.
- W1837421878 hasVolume "75" @default.
- W1837421878 isParatext "false" @default.
- W1837421878 isRetracted "false" @default.
- W1837421878 magId "1837421878" @default.
- W1837421878 workType "article" @default.